Biontech achieves milestone at mrna-based vaccine manufacturing site in rwanda

Kigali, rwanda, december 18, 2023 (globe newswire) – biontech se (nasdaq: bntx, “biontech” or “the company”) has reached the next milestone in the establishment of mrna vaccine manufacturing capacities in africa with the inauguration of the company's site in kigali, rwanda. the inauguration takes place on the occasion of the set-up of the first manufacturing unit called biontainer. this effort is one of biontech's multiple initiatives aimed at helping to build a sustainable and resilient african vaccine ecosystem and supporting equitable access to novel medicines globally: these cover research and development, clinical trials, manufacturing and local training of specialized personnel.
BNTX Ratings Summary
BNTX Quant Ranking